Results 101 to 110 of about 22,584,734 (247)

Proliferation of T lymphocytes in response to interleukin 2 varies with their state of activation. [PDF]

, 1986
Jonathan D. Ashwell, R J Robb, Thomas R. Malek   +2 more
openalex   +1 more source

Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level. [PDF]

, 1985
John C. Reed, W C Greene, R G Hoover, Peter C. Nowell̀   +3 more
openalex   +1 more source

Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Immunity, 2013
W. Liao, Jian-Xin Lin, W. Leonard
semanticscholar   +1 more source

Selectivity of bovine interleukin-2 mutein stimulation on bovine peripheral blood mononuclear cells. [PDF]

J Vet Med Sci
Mitoma S, Uto T, Fukaya T, Tominaga M, Sekiguchi S, Sato K, Norimine J.   +6 more
europepmc   +1 more source

Purification of mouse interleukin 2 to apparent homogeneity.

, 1983
Denis Riendeau, D G Harnish, R. Chris Bleackley, Verner Paetkau   +3 more
openalex   +1 more source

B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. [PDF]

, 1988
Martin Lotz, Frank R. Jirik, Panagiotis S. Kabouridis, Constantine D. Tsoukas, T Hirano, Tadamitsu Kishimoto, Dennis A. Carson   +6 more
openalex   +1 more source

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation.

Immunity, 2007
A. Laurence, C. Tato, Todd S. Davidson, Y. Kanno, Zhi Chen, Zhengju Yao, R. Blank, F. Meylan, R. Siegel, L. Hennighausen, E. Shevach, J. O’Shea   +11 more
semanticscholar   +1 more source

The Impact of Nursing Interventions on the Treatment Outcomes of Renal Cell Carcinoma with Postoperative Interleukin-2 and Recombinant Human Interferon

Journal of Multidisciplinary Healthcare
Li Guo,1 Li-Qin Zhao,2 Jin-Yu Chen,2 Ming Li2 1Third Department of General Surgery (Breast Armor Surgery), Ezhou Central Hospital, Ezhou City, 436000, People’s Republic of China; 2Department of Oncology, Ezhou Central Hospital, Ezhou City, 436000, People’
Guo L, Zhao LQ, Chen JY, Li M
doaj  

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. [PDF]

, 1984
A. Fontana, Hans Hengartner, Nicolas de Tribolet, Elisabeth Weber   +3 more
openalex   +1 more source

Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia. [PDF]

Ther Adv Hematol
Nilsson MS, Martner A, Wennström L, Hansson M, Thorén FB, Hellstrand K.   +5 more
europepmc   +1 more source